Riskpilot← Back to searchSign inGet full accessApodemus Aktiebolag
ABActiveOrg 5560767641KalmarResearch and experimental development on natural sciences and engineering · NACE 7210Est. 19613 employees
Revenue 2024
SEK 2,4M
-40% vs 2023
EBITDA margin
7.7%
+68% vs 2023
Equity ratio
64.9%
Financial strength
Net profit 2024
SEK 341K
+402% vs 2023
| Revenue | SEK 2,4M | -40% |
| EBITDA | SEK 183K | +68% |
| Net profit | SEK 341K | +402% |
| Total assets | SEK 6,4M | -33% |
| Equity | SEK 4,2M | +9% |
| Employees | 3 | — |
Legal name
Apodemus Aktiebolag
Org number
5560767641
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25 januari 1961
Share capital
SEK 4 418 303
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Claesson, Per Johan Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget skall bedriva forskning och utveckling, konsultverksamhet, kliniskt arbete och utbildning inom infektionsmedicin och mikrobiologi, köpa och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Kalmar
Email
elisabeth.grahn@cafastigheter.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 314 | 4 489 | 3 833 | 3 925 | 2 373 |
| Staff expenses | — | — | — | — | −2 073 |
| EBITDA | −524 | 259 | −1 | 109 | 183 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −524 | 259 | −1 | 109 | 183 |
| Net financials | −34 | −59 | −42 | −41 | 158 |
| Profit before tax | −558 | 200 | −43 | 68 | 341 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −558 | 200 | −43 | 68 | 341 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 516 | 7 353 | 5 857 | 9 614 | 6 414 |
| Equity | 3 596 | 3 796 | 3 753 | 3 821 | 4 162 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 2 920 | 3 557 | 2 104 | 5 793 | 2 252 |
| Total debt | 2 920 | 3 557 | 2 104 | 5 793 | 2 252 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20202024
Equity ratio
64.9%
This company
38.2%
Market median
+70% vs market
20202024
Return on equity
8.2%
This company
18.4%
Market median
-55% vs market
20202024
Net profit margin
14.4%
This company
8.1%
Market median
+78% vs market
20202024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20202024
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LT Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Apodemus Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linda-Marie Thérése Emilsson | Chief Auditor | 0 companies |
| Eva Pernilla Claesson | Board of Directors | 0 companies |
| Greta Marianne Claesson | Deputy Board Member | 0 companies |
| Malin Helena Claesson Stenström | Board of Directors | 0 companies |
| Per Johan Claesson | Chairman | 0 companies |